Metelitsa LS - Search Results

1

Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.

Ara T, Song L, Shimada H, Keshelava N, Russell HV, Metelitsa LS, Groshen SG, Seeger RC, DeClerck YA. Ara T, et al. Among authors: metelitsa ls. Cancer Res. 2009 Jan 1;69(1):329-37. doi: 10.1158/0008-5472.CAN-08-0613. Cancer Res. 2009. PMID: 19118018 Free PMC article.

2

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.

Maurer BJ, Metelitsa LS, Seeger RC, Cabot MC, Reynolds CP. Maurer BJ, et al. Among authors: metelitsa ls. J Natl Cancer Inst. 1999 Jul 7;91(13):1138-46. doi: 10.1093/jnci/91.13.1138. J Natl Cancer Inst. 1999. PMID: 10393722

3

Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.

Erdreich-Epstein A, Shimada H, Groshen S, Liu M, Metelitsa LS, Kim KS, Stins MF, Seeger RC, Durden DL. Erdreich-Epstein A, et al. Among authors: metelitsa ls. Cancer Res. 2000 Feb 1;60(3):712-21. Cancer Res. 2000. PMID: 10676658

4

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow.

Hoon DS, Kuo CT, Wen S, Wang H, Metelitsa L, Reynolds CP, Seeger RC. Hoon DS, et al. Am J Pathol. 2001 Aug;159(2):493-500. doi: 10.1016/S0002-9440(10)61721-X. Am J Pathol. 2001. PMID: 11485908 Free PMC article.

5

Human NKT cells mediate antitumor cytotoxicity directly by recognizing target cell CD1d with bound ligand or indirectly by producing IL-2 to activate NK cells.

Metelitsa LS, Naidenko OV, Kant A, Wu HW, Loza MJ, Perussia B, Kronenberg M, Seeger RC. Metelitsa LS, et al. J Immunol. 2001 Sep 15;167(6):3114-22. doi: 10.4049/jimmunol.167.6.3114. J Immunol. 2001. PMID: 11544296

6

Antidisialoganglioside/granulocyte macrophage-colony-stimulating factor fusion protein facilitates neutrophil antibody-dependent cellular cytotoxicity and depends on FcgammaRII (CD32) and Mac-1 (CD11b/CD18) for enhanced effector cell adhesion and azurophil granule exocytosis.

Metelitsa LS, Gillies SD, Super M, Shimada H, Reynolds CP, Seeger RC. Metelitsa LS, et al. Blood. 2002 Jun 1;99(11):4166-73. doi: 10.1182/blood.v99.11.4166. Blood. 2002. PMID: 12010822 Free article.

7

Expression of CD1d by myelomonocytic leukemias provides a target for cytotoxic NKT cells.

Metelitsa LS, Weinberg KI, Emanuel PD, Seeger RC. Metelitsa LS, et al. Leukemia. 2003 Jun;17(6):1068-77. doi: 10.1038/sj.leu.2402943. Leukemia. 2003. PMID: 12764370

8

Natural killer T cells infiltrate neuroblastomas expressing the chemokine CCL2.

Metelitsa LS, Wu HW, Wang H, Yang Y, Warsi Z, Asgharzadeh S, Groshen S, Wilson SB, Seeger RC. Metelitsa LS, et al. J Exp Med. 2004 May 3;199(9):1213-21. doi: 10.1084/jem.20031462. J Exp Med. 2004. PMID: 15123743 Free PMC article.

9

Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans.

Baev DV, Peng XH, Song L, Barnhart JR, Crooks GM, Weinberg KI, Metelitsa LS. Baev DV, et al. Among authors: metelitsa ls. Blood. 2004 Dec 15;104(13):4150-6. doi: 10.1182/blood-2004-04-1629. Epub 2004 Aug 24. Blood. 2004. PMID: 15328159 Free article.

10

Synthesis and evaluation of an alpha-C-galactosylceramide analogue that induces Th1-biased responses in human natural killer T cells.

Lu X, Song L, Metelitsa LS, Bittman R. Lu X, et al. Among authors: metelitsa ls. Chembiochem. 2006 Nov;7(11):1750-6. doi: 10.1002/cbic.200600197. Chembiochem. 2006. PMID: 17009272

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page